Akebia Therapeutics
AKBA
AKBA
65 hedge funds and large institutions have $30.9M invested in Akebia Therapeutics in 2023 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 15 increasing their positions, 15 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
0.2% less ownership
Funds ownership: 28.41% → 28.21% (-0.2%)
13% less funds holding
Funds holding: 75 → 65 (-10)
50% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 16
Holders
65
Holding in Top 10
1
Calls
$466K
Puts
$81K
Top Buyers
| 1 | +$1.83M | |
| 2 | +$713K | |
| 3 | +$625K | |
| 4 |
Morgan Stanley
New York
|
+$170K |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$133K |
Top Sellers
| 1 | -$767K | |
| 2 | -$457K | |
| 3 | -$307K | |
| 4 |
Jane Street
New York
|
-$268K |
| 5 |
Millennium Management
New York
|
-$242K |